Hemab ApS

Hemab ApS (CVR number: 40837590) is a company from FREDERIKSBERG. The company recorded a gross profit of 0 kDKK in 2022. The operating profit was -161.5 mDKK, while net earnings were -156.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was -288.2 %, which can be considered poor and Return on Equity (ROE) was -421.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 18.5 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Hemab ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.